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Immune Response in Stat2 Knockout Mice
genes through members of the g activation site (GAS)Christopher Park,* Suzanne Li,†
family of enhancers. GAS-driven genes including IRF-1,Edward Cha,* and Christian Schindler*‡
CIITA (an activator MHC class II), IGTP, MIG, and IP-10*Departments of Microbiology and Medicine
(Decker et al., 1997; Taylor et al., 2000). Consistent withColumbia University
these observations, Stat1 knockout mice are defective†Department of Cell Biology
in their response to both type I and type II IFNs (DurbinMemorial Sloan Kettering Cancer Institute
et al., 1996; Meraz et al., 1996). Thus, Stat2, an uncharac-New York, New York 10021
teristic member of the STAT family (Park et al., 1999),
is unique to the biological response to type I IFNs.
Receptor gene targeting studies have provided impor-Summary
tant insight into the distinct biological responses to type
I and II IFNs. Specifically, type I IFN receptor a chainType I IFNs induce gene expression through Stat1 and
(IFNAR1) null mice are exquisitely sensitive to infectionStat2, which can in turn associate either to form Stat1
with vesicular stomatitis virus (VSV), semliki forest virushomodimers or the transcription factor ISGF-3. Stat1
(SFV), vaccinia virus (VV), and lymphocytic choriomenin-homodimers also transduce signals for IFN-g. To ex-
gitis virus (LCMV) but not to intracellular pathogensplore the unique properties of Stat2 and ISGF-3 in type
(Mu¨ller et al., 1994). In contrast, IFN-g and IFN-g receptorI IFN signaling, its gene was targeted for deletion.
null mice are defective in their response to VV and LCMVStat2 null mice exhibit a number of defects in immune
but not VSV and SFV (Dalton et al., 1993; Huang et al.,response. This includes an increased susceptibility to
1993; Lu et al., 1998). These mice are also uniquelyviral infection and the loss of a type I IFN autocrine/
sensitive to infection with obligate intracellular patho-paracrine loop, which in turn regulates several aspects
gens and exhibit notable perturbations in cellular im-of immune response. Intriguingly, Stat2-deficient fi-
munity.broblasts exhibit a more significant defect in their re-
Although type I IFNs are well recognized for their rolesponse to type I IFNs than macrophages, highlighting
in promoting innate antiviral immunity, numerous stud-tissue-specific differences in the response to this fam-
ies have hinted at a more pervasive role in immuneily of ligands.
response (Biron, 1998). Recent studies have determined
that a circulating dendritic cell precursor secretes largeIntroduction
quantities of type I IFNs in response to infectious stimuli
(Siegal et al., 1999). Type I IFNs have also recently beenType I interferons (IFNs) mediate potent antiviral and
implicated in promoting the survival of memory T cells,antiproliferative activities on target cells through the ac-
especially from the CD81 lineage (Tough et al., 1996;tivation of new genes. Characterization of their ability
Marrack et al., 1999). This activity contrasts the sup-to induce these genes led to the elucidation of the JAK-
pressive effects ascribed to type I IFNs on earlier eventsSTAT signaling pathway, where Janus kinases (JAKs)
in lymphopoiesis (Binder et al., 1997; Lin et al., 1998).are receptor-associated tyrosine kinases and signal
The recent identification of limitin, a stromally secretedtransducers and activators of transcription (STATs) are
type I IFN that antagonizes lymphopoiesis, further impli-the transcription factors they activate. Subsequent stud-
cates type I IFNs in the regulation of lymphoid develop-ies have determined that most other members of the
ment (Oritani et al., 2000).cytokine family transduce vital signals through this para-
Type I IFNs have also been shown to function through
digm (reviewed in Ihle, 1995; Darnell, 1997; Schindler
an autocrine loop. Initial studies highlighted the ability
and Strehlow, 2000).
of type I IFNs to antagonize the growth of several tumor
Type I IFN (e.g., IFN-a/b) signaling entails the rapid lines through this loop (Resnitzky et al., 1986; Mattei et
receptor-dependent activation of Stat1 and Stat2. Once al., 1994; Kawabata et al., 1997). Subsequent biochemi-
activated, these two STATs can either heterodimerize, cal and genetic studies have provided further and com-
associate with the DNA binding protein IRF-9 (p48) and pelling evidence that this type I IFN autocrine loop is
form ISGF-3 (IFN-stimulated gene factor-3), or they can critical for the robust secretion of type I IFNs in response
form Stat1 homodimers (Darnell, 1997; Schindler and to viral infection and the antiviral activity of IFN-g (Er-
Strehlow, 2000). ISGF-3 promotes the activation of landsson et al., 1998; Wathelet et al., 1998; Takaoka et
genes through the IFN-stimulated response element al., 2000). This may reflect the role of “early” type I IFNs
(ISRE). ISRE-driven genes include Ly-6C, the double- as components of an autocrine loop that promotes the
stranded RNA kinase (PKR), 29 to 59 oligoadenylate syn- robust secretion of “late” type I IFNs (Erlandsson et al.,
thase (OAS), MX, and potentially MHC class I (Bothwell 1998; Marie et al., 1998; Sato et al., 1998; Takaoka et
et al., 1988; Johnson and Pober, 1994; Stark et al., 1998; al., 2000).
Lee et al., 1999). Stat1 homodimers, which also play a To address the unique properties of Stat2 in IFN signal-
critical role in transducing signals for IFN-g (Durbin et ing, the Stat2 gene has been targeted for deletion by
al., 1996; Meraz et al., 1996), promote the activation of homologous recombination. As anticipated, Stat2 knock-
out mice are unresponsive to type I IFNs and exquisitely
sensitive to viral infection. However, they also exhibit a‡ To whom correspondence should be addressed (e-mail: cws4@
columbia.edu). number of additional significant defects, including the
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Figure 1. Generation of Stat2 Null Mice
(A) Schematic representation of the Stat2 targeting construct and z14 kb of the endogenous murine Stat2 gene. The positions of exons one
through eight are indicated along with informative endonuclease restriction sites (H, HindIII; B, BamHI; S, SalI; X, XbaI; and P, PstI). Double-
sided arrows indicate the position of diagnostic restriction fragments used in genotyping with probes P and SB. Asterisks indicate the location
of primers employed for PCR genotyping.
(B) Representative Southern blot of BamHI restricted DNA prepared from wild-type (1/1), Stat21/2, and Stat22/2 tail DNA and then hybridized
with SB. The relative position of the wild-type (WT) and Stat2 null (KO) allele is indicated in the right margin.
(C) Representative Stat2 and Stat1 immunoblot of whole-cell extracts prepared from wild-type (1/1), Stat21/2, and Stat22/2 PMEFs. The
relative positions of murine Stat1 (MuStat1) and murine Stat2 (MuStat2) are indicated in the left margin.
loss of the type I IFN autocrine loop and unique defects resistance cassette (Figure 1A) was introduced into ES
cells. Heterozygous Stat2 knockout mice were gener-in macrophage and T cell responses. Characterization
of Stat22/2 cell types highlights important tissue-specific ated from successfully targeted embryonic stem (ES)
cells (Figure 1B). Interbreeding of heterozygous micedifferences Stat2 plays in mediating the biological re-
sponse to IFN-a. These observations indicate that Stat2 yielded Stat2 null mice at the expected Mendelian ratio.
The Stat2 null mice developed and bred normally in ais critical to the biological response of type I IFNs and
demonstrate that this subfamily of IFNs plays a more specific pathogen free (SPF) environment. Consistent
with the genotyping data (Figure 1B), extracts preparedpervasive role in immune response than had been antici-
pated. from Stat2 null primary embryonic fibroblasts (PMEFs)
did not express Stat2 protein (Figure 1C). Moreover,
heterozygous (i.e., Stat21/2) PMEFs exhibit an z50%Results
reduction in Stat2 protein level (Figure 1C), suggesting
a gene dosage effect. Notably, there was also z50%Targeting Stat2 for Deletion
A targeting construct designed to replace the first four reduction in the level of Stat1 expression in Stat2 null
cells, indicating that the basal level of Stat1 in PMEFsexons of the Stat2 gene (7 kb) with a pGK-neomycin
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activities correlated directly with robust Stat1 and Stat2
tyrosine phosphorylation (data not shown).
Type I IFNs also promote the formation of Stat1 homo-
dimers, albeit at modest levels. To evaluate this re-
sponse, PMEF extracts were evaluated with a GAS
probe. As anticipated, IFN-g stimulated a robust GAS
binding activity (i.e., Stat1 homodimers), which could be
supershifted with a Stat1-specific antibody (Figure 2B).
No significant differences were noted in extracts pre-
pared from knockout (i.e., Stat21/2 and Stat22/2) cells
after stimulation with a standard amount of IFN-g (Meraz
et al., 1996). Slightly faster migrating Stat1b homodimers
were also readily apparent in the IFN-g-stimulated sam-
ples. The GAS binding activity recovered from IFN-a-
stimulated cells was, however, considerably more mod-
est. It was even further reduced in the Stat21/2 and
Stat22/2 cells, suggesting that Stat2 contributes to the
IFN-a-dependent activation of Stat1, as had recently
been observed in a Stat2-deficient tumor line (Leung et
al., 1995; Farrar et al., 2000).
Evaluation of STAT-Dependent Gene Expression
Type I IFNs mediate their biological effects through the
induction of new genes. This predominately includes
genes whose expression is dependent on ISGF-3 (i.e.,
ISRE-driven genes). The response of GAS-driven genes
(i.e., Stat1 homodimer dependent) has been reported to
be considerably more modest. To evaluate IFN-depen-
dent gene expression, RNA was prepared from PMEFsFigure 2. IFN-Dependent Activation of STAT Transcription Factors
before or after stimulation with a standard dose of IFN-a.in Stat2 Null PMEFs
This RNA was fractionated and then sequentially hybrid-(A) IFN-dependent activation of ISGF-3. Whole-cell extracts were
prepared from wild-type (1/1), Stat21/2, and Stat22/2 PMEFs, both ized with probes for known ISRE-driven (e.g., MxA, OAS,
before and after stimulation with IFN-a (1000 U/ml; 20 min) or IFN-g and PKR; Stark et al., 1998; Schindler and Strehlow,
(66 U/ml; 20 min). The extracts were then evaluated by EMSA with 2000) and GAS-driven genes (e.g., IRF-1 and IGTP; Pine
an OAS ISRE probe. In lanes 11 and 12, wild-type (1/1) extracts
et al., 1994; Taylor et al., 2000). Stat1 and GAPDH probeswere supershifted by the addition of either preimmune serum (PIS)
were included as controls. As anticipated, IFN-a failedor a Stat2-specific antibody (aSt2), 30 min prior to incubation with
to induce the expression of ISGF-3 target genes (i.e.,probe. The mobility of ISGF-3 is indicated in the left margin.
(B) IFN-dependent activation of Stat1 homodimers. Whole-cell ex- Mx, OAS, and PKR) in Stat2 null cells (Figure 3A). Two
tracts from (A) were evaluated by EMSA with an IRF-1 GAS probe. of these genes (i.e., Mx and OAS) demonstrated a signifi-
In lanes 11 and 12, wild-type (1/1) extracts were supershifted by cantly reduced level of expression in Stat21/2 cells, con-
the addition of either preimmune serum (PIS) or a Stat1-specific
sistent with their reduced levels of ISGF-3 found in thoseantibody (aSt1), 30 min prior to incubation with probe. The mobility
cells (Figure 2). The pattern of Stat1 expression paral-of Stat1 homodimers is indicated in the left margin.
leled that of an ISRE-driven gene. This observation,
along with evidence supporting the existence of a type
I IFN autocrine loop (Erlandsson et al., 1998; Sato etis dependent on Stat2 (see below). In sum, these studies
demonstrated that the Stat2 locus had been effectively al., 1998; Takaoka et al., 2000), provides a potential
explanation for the lower level of Stat1 found in Stat22/2targeted.
fibroblasts.
When GAS-driven genes were examined, a differentEvaluation of STAT Activation
Type I IFNs transduce signals through the activation of pattern emerged. As anticipated, IFN-g potently induced
IGTP and IRF-1 (Figure 3B). IFN-g-dependent expres-ISGF-3. To evaluate ISGF-3 activation, extracts were
prepared from PMEFs before and after stimulation with sion was robust in Stat21/2 and Stat22/2 cells as well,
suggesting that the reduced levels of Stat1 were notIFN-a and examined by electrophoretic mobility shift
assay (EMSA) with an ISRE probe (Figure 2A). As antici- significant for this pathway. In contrast, IFN-a-depen-
dent induction of these genes was modest in wild-typepated, stimulation with IFN-a led to a robust induction
of ISGF-3 in wild-type cells, which could in turn be “su- PMEFs and absent in the Stat22/2 cells. This paralleled
the lower levels of Stat1 homodimer activity recoveredpershifted” with a murine Stat2-specific antibody (Park
et al., 1999). However, this complex was absent in Stat2 from these cells and suggested that IFN-a-stimulated
activation of Stat1 may be Stat2-dependent in fibro-null cells. Consistent with a decrease in the levels of
Stat2 and Stat1, ISGF-3 formation was also modestly blasts. A similar conclusion has been reached in a Stat2-
deficient human tumor fibroblast line (Leung et al., 1995;reduced in heterozygous Stat2 null cells. As anticipated,
stimulation with IFN-g did not lead to the formation of Farrar et al., 2000).
To explore the potential effect of a loss of Stat2 on IFNnotable levels of ISGF-3 activity. These DNA binding
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this locus appears to involve three enhancers (i.e., en-
hancer A, the IFN consensus site, and site-a), at least
one of these sites is ISRE like, and Stat1 has been shown
to be required for the response to IFNs (Johnson and
Pober, 1994; Meraz et al., 1996; Lee et al., 1999). As
anticipated, stimulation of wild-type PMEFs with IFN-a
or IFN-g led to a robust increase in MHC class I expres-
sion (Figure 4A, left). The response to IFN-a was, how-
ever, reduced in Stat21/2 PMEFs and absent in Stat22/2
PMEFs. This paralleled the pattern observed with ISRE-
driven genes in our Northern blotting analysis (Figure
3A). The response to IFN-g was, however, unaffected
by the loss of Stat2. When MHC I expression was evalu-
ated in peritoneal macrophages, a different pattern
emerged. Again, IFN-a and IFN-g both stimulated a ro-
bust increase in MHC I cell surface expression in wild-
type cells (Figure 4A, middle). Remarkably, this pattern
did not change in heterozygous and homozygous null
cells, indicating that both IFN-a and IFN-g will upregu-
late MHC I expression in a Stat2-independent manner
in macrophages.
Struck by the difference in IFN-a-dependent regula-
tion of MHC class I observed in primary fibroblasts and
macrophages, a number of additional studies were car-
ried out. We focused our attention on Stat1, because
previous studies had suggested that IRF-1, a GAS-
driven gene, may mediate the IFN-a-dependent regula-
tion of MHC class I (Johnson and Pober, 1994). First,
MHC class I expression was evaluated in macrophages
collected from Stat1/Stat2 double knockout mice (Fig-
ure 4B, left). These cells were unable to significantly
upregulate MHC class I expression in response to either
IFN-a or IFN-g, suggesting that Stat1 is the critical regu-
lator. Since studies in Stat22/2 PMEFs had determined
that Stat1 levels were diminished and that this may have
contributed to a defect in the regulation of GAS-driven
genes by IFN-a, Stat1 protein levels were evaluated in
macrophages. In striking contrast to PMEFs, Stat22/2
macrophages exhibited normal levels of Stat1 protein
(Figure 4B, middle). Finally, the ability of IFN-a to directly
regulate GAS-driven genes was evaluated in macro-
phages. Due to the intrinsic limitations in recovering
RNA from this tissue, an RT-PCR analysis was per-
formed (Figure 4B, right). The IFN-a-stimulated expres-
sion of three GAS-driven genes (i.e., IRF-1, IP-10, and
MIG) was normal in Stat22/2 macrophages but not in
Stat12/2 or Stat1/Stat2 double knockout (dko) macro-
Figure 3. Evaluation of IFN-Dependent Gene Expression by North- phages. These observations highlight an important in-
ern Blotting trinsic difference between macrophages and fibroblasts
(A) Twenty micrograms of total RNA was prepared from wild-type regarding the IFN-a-dependent regulation of GAS-
(1/1), Stat21/2, and Stat22/2 PMEFs, both before and after stimula- driven genes (which in turn regulate MHC class I expres-
tion with IFN-a (1000 U/ml; 6 hr) or IFN-g (66 U/ml; 2 hr). The blot sion) (Johnson and Pober, 1994; Martin et al., 1997).
was then fractionated and sequentially hybridized with probes for Lymphocytes were the final primary tissue in whichMxA, OAS, Stat1, PKR, and GAPDH.
IFN-a-dependent gene expression was evaluated. For(B) Twenty micrograms of total RNA was prepared from wild-type
this study, Ly-6C, a T cell–specific marker whose ex-(1/1), Stat21/2, and Stat22/2 PMEFs, both before and after stimula-
pression is known to be upregulated by type I IFNs, wastion with IFN-a (1000 U/ml; 2 hr) or IFN-g (66 U/ml; 2 hr). The blot
was then fractionated and sequentially hybridized with probes for evaluated (Bothwell et al., 1988; Lin et al., 1998). Wild-
IGTP, IRF-1, and GAPDH. type T cells exhibited a bimodal pattern of Ly-6C expres-
sion, suggesting a significant level of basal expression
(Figure 4A, right). As anticipated, the level of Ly-6C in-
signaling in hematopoietic lineages, the IFN-dependent creased with IFN-a treatment. In contrast, both basal
expression of two cell surface proteins was examined. and IFN-a-dependent Ly-6C expression was reduced in
MHC class I expression was evaluated first, because it Stat21/2 T cells and absent in Stat22/2 T cells. This gene
provided an opportunity to compare responses between dosage effect was reminiscent of what had been ob-
served in fibroblasts and indicated that Stat2 regulatesmacrophages and fibroblasts. Although regulation of
Stat2 Knockout
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Figure 4. IFN-Dependent Expression of Cell Surface Proteins in Stat2 Null Leukocytes
(A) Wild-type (1/1), Stat21/2, and Stat22/2 PMEFs, splenocytes, or resident peritoneal macrophages were evaluated either before or after
stimulation with IFN-a (1000 U/ml; 72 hr) or IFN-g (66 U/ml; 72 hr) by flow cytometry. Fibroblasts (PMEFs) were then stained with antibodies
specific for MHC class I (H-2Kb). Macrophages were stained for Mac-1, MHC I (H-2Kb), and an isotype-matched control (Iso). Splenocytes
were stained for Ly-6C and CD3. Histograms represent the expression of MHC I and Ly-6C on the appropriately gated cells. These results
are each representative of three independent experiments.
(B) (Left) Stat12/2/Stat22/2 resident peritoneal macrophages were stained for Mac-1, MHC I (H-2Kb), and an Iso, before and after IFN stimulation,
as outlined in (A). (Middle) Whole-cell extracts, prepared from Stat21/1 and Stat22/2 macrophages (Macs) and PMEFs, were adjusted for protein
concentration and sequentially immunoblotted with Stat1 (a-MuStat1), Stat2 (a-MuStat2), and b-actin-specific (a-b-actin) antibodies. (Right)
RT-PCR analysis of RNA prepared from unstimulated, IFN-a-stimulated, or IFN-g-stimulated peritoneal macrophages harvested from wild-
type (Stat21/1), Stat22/2, Stat12/2, and Stat1/Stat2 double knockout (St1/St2 dko) mice.
both IFN-a-dependent and basal Ly-6C expression. This IFN-g led to the anticipated 3–4 log reduction in viral
yield. The pattern of response of Stat21/2 cells closelylatter observation supports the existence of an autocrine
resembled that of wild-type PMEFs. In contrast, Stat22/2(or paracrine) type I IFN loop that constitutively regulates
PMEFs were afforded virtually no protection by IFN-alymphocytes.
pretreatment (i.e., only 40-fold). Unexpectedly, IFN-g
failed to induce an antiviral response in Stat22/2 cells.
Antiviral Response of Stat2 Null Cells However, previous studies with IFNAR1 (IFN-a receptor
IFNs were initially identified for their ability to antagonize chain 1) null fibroblasts had indicated that IFN-g pro-
viral infections in cultured cells. To evaluate this re- motes its in vitro antiviral activity, at least in part, through
sponse in Stat2-deficient tissues, PMEFs from wild-type the induction of type I IFNs (i.e., an autocrine loop; Mu¨ller
(WT), Stat21/2, and Stat22/2 mice were infected with VSV et al., 1994; Takaoka et al., 2000). This provided a partial
and then evaluated by a sensitive viral yield assay. explanation for our observation. The reduced levels of
Stat21/2 and Stat22/2 PMEFs, respectively, produced Stat1 in the Stat22/2 cells may account for the remaining
z10 and z40 times more virus (i.e., plaque-forming units deficit. Similar observations were obtained with a cyto-
[pfu]) than wild-type cells (Table 1, experiment 1). Treat- pathic effect assay (Mu¨ller et al., 1994).
Our preceding biochemical studies supported the ex-ment of wild-type cells with standard doses of IFN-a or
Immunity
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Table 2. Splenic and Hepatic Viral Burdens from VSV-InfectedTable 1. Viral Yield from VSV-Infected Murine Embryonic
Fibroblasts Mice
Experiment 1 Genotype Spleen Liver
Genotype Unstim. IFN-a IFN-g wt 1.60 3 103 6 657 59.5 6 13.1
St22/2 5.48 3 107 6 2.30 3 107 1.23 3 107 6 1.55 3 107
wt 1 1.1 3 1023 2.1 3 1024 St12/2 6.97 3 107 6 5.89 3 107 1.59 3 107 6 5.65 3 106
St21/2 10.9 1.1 3 1023 2.2 3 1022 St1/St2 dko 4.18 3 108 6 1.25 3 108 6.51 3 108 6 2.32 3 108
St22/2 38.9 45.3 1.1
Thirty-six hours after intravenous infection with 4 pfu of VSV, spleensExperiment 2
and livers were harvested. Viral burden (pfu/g) was determined by
Genotype Relative Titer measuring the viral titer of organ homogenates on HeLa cells. Or-
gans from four mice were included in each group.wt 1
St21/2 18.3
St22/2 83.5
IFNAR12/2 45.7
Antiviral Response of Stat2 Null Mice
Experiment 3 Studies with IFN receptor knockout mice have deter-
Genotype Relative Titer mined that type I but not type II IFNs mediate a potent
wt 1 innate antiviral response to VSV infection (Mu¨ller et al.,
St21/2 12 1994). That is, IFNAR12/2 mice were found to be exqui-
St22/2 26.2
sitely sensitive to infection with low doses of virus. Con-St22/2 1 St22 6.92
sistent with the requirement of Stat1 for ISGF-3 forma-St22/2 1 St21 10.85
tion, Stat1 null mice exhibited a similar increase in theirSt12/2 8.31
susceptibility to VSV infection (Meraz et al., 1996). In
Murine embryonic fibroblasts (2 3 104/well) were stimulated for 24 hr
our studies, wild-type and Stat21/2 mice were resistantwith IFN (IFN-aA/D at 1000 U/ml or IFN-g at 66 U/ml), prior to infection
to infection with doses of VSV of 2.5 3 106 pfu (HeLa cellwith VSV (multiplicity of infection [MOI] 5 1 3 1026; 2 hr). Twenty-
four hours postinfection, supernatants were collected and titered units). However, Stat1 and Stat2 null mice succumbed to
on HeLa cells. Results are presented as the relative titer, compared infection with doses that were z6 logs lower. The major-
to that obtained with wild-type embryonic fibroblasts. The fibro- ity of Stat12/2 and Stat22/2 mice died between 3 to 6
blasts employed in experiments one and two were primary, whereas days after infection with doses of 1–3 pfu of VSV. Al-
those in experiment three were immortalized (i.e., by crisis). Each
though there was a modest trend toward earlier deathof the results are representative of three independent experiments.
in the Stat22/2 mice, this was more apparent when Stat1/
Stat2 double knockout mice were infected with VSV. In
an effort to quantitate these differences more accu-istence of a type I IFN autocrine loop. This suggested
that Stat22/2 cells should be inherently more sensitive rately, viral burdens in the spleen and liver were deter-
mined 36 hr postinfection in all three lines of mice (Tableto viral infection. Consistent with this prediction, unstim-
ulated Stat22/2 PMEFs produced on average z60-fold 2). As anticipated, these viral burdens were low in wild-
type mice, especially in liver. Both the Stat12/2 andmore virus than wild-type PMEFs (Table 1, experiments
1 and 2). Providing independent support for the exis- Stat22/2 mice exhibited substantially larger (i.e., up to 5
logs), yet similar, viral burdens. The viral burdens weretence of a type I IFN autocrine loop, IFNAR12/2 PMEFs
exhibited an analogous pattern of increased viral pro- modestly higher in the Stat1/Stat2 double knockout
mice. The demonstration of parity in the viral burdensduction. Consistent with the gene dosage effect ob-
served in DNA binding and gene expression studies, in Stat1- and Stat2-deficient mice is consistent with the
notion that a Stat1-Stat2 heterodimer (i.e., ISGF-3) playsthe Stat21/2 cells exhibited an intermediate phenotype.
Similar observations were made with immortalized mu- the critical role in mediating antiviral responses. How-
ever, the modestly elevated sensitivity of double knock-rine embryonic fibroblasts (i.e., MEFs; see Table 1, ex-
periment 3). out mice leaves open the possibility that these transcrip-
tion factors may transduce some independent signalsTo confirm that defects found in Stat2 knockout cells
were solely due to the loss of Stat2, Stat2 expression (e.g., Stat1 homodimers).
was reestablished in Stat22/2 MEFs through stable trans-
fection. Cells stably reexpressing Stat2 were selected Lymphocyte Function in Stat2 Null Mice
Recent studies have suggested that type I IFNs regulateby their ability to upregulate expression of MHC I in
response to IFN-a. Two pools of “rescued” cells (i.e., the maturation of lymphocytes. Resident bone marrow
macrophages and stromal fibroblasts have been shownStat22/2 1 St21 and Stat22/2 1 St22) were collected and
evaluated for their biological response to IFN-a. The to secrete type I IFNs, which can impair lymphoid prolif-
eration and maturation (Wang et al., 1995; Pilling et al.,ability of these cells to form ISGF-3 and activate target
genes was effectively restored (data not shown). Consis- 1999; Oritani et al., 2000). Either virally induced or admin-
istered type I IFNs will block the development of B cellstent with a good but incomplete restoration in IFN-a
signaling, these cells exhibited an intrinsic ability to re- and T cells (Binder et al., 1997; Lin et al., 1998). Careful
analysis of these T cells has determined the block tosist viral infection that was similar to Stat21/2 MEFs
(Table 1, experiment 3). In sum, these studies confirm occur during the pro-T cell stage differentiation, leading
to a profound loss in double-positive (i.e., CD41/CD81)that defects in the biological responses observed in
Stat22/2 cells can be attributed to a single gene, Stat2, thymocytes (Lin et al., 1998).
Our preceding studies (Figure 4A) had already docu-and provide further support for the existence of a type
I IFN autocrine loop. mented a significant defect in the ability of IFN-a to
Stat2 Knockout
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induce Ly-6C expression in Stat22/2 T cells. To extend
this analysis to the antiproliferative activity of type I IFN
on T cells, splenic lymphocytes were harvested. When
wild-type and Stat22/2 cells were stimulated with conca-
navalin A (Con A; a T cell mitogen), they exhibited the
anticipated increase in proliferation, as measured by
propidium iodide staining. However, the ability of IFN-a
to block the proliferative response was lost in the Stat22/2
lymphocytes (data not shown).
Next, the potential role of IFNs in T cell expansion
was evaluated in vivo. Mice were challenged with an
injection of dexamethasone, which is known to promote
a dramatic loss of CD4/CD8 double-positive T cells
(Wang et al., 1999). This is normally followed by a burst
of lymphopoiesis that first entails a transient increase in
a CD81/CD3lo precursor population. These cells rapidly
mature into CD41/CD81 T cells, which then give rise to
CD4/CD3hi and CD8/CD3hi single-positive cells that are
found in the periphery. When wild-type and Stat2 null
mice were injected with dexamethasone, double-posi-
tive thymocytes were largely eliminated by 2 days (i.e.,
the nadir; Figure 5). There was, however, a slight sugges-
tion that Stat22/2 mice were beginning to repopulate the
CD81 and CD41/CD81 populations. Two days later (i.e.,
day 4 postdexamethasone), the difference between
wild-type and Stat2 null mice was striking. Wild-type
mice had exhibited a dramatic increase in their CD81
population (49% versus 23.9%), whereas the Stat2 cells
had already substantially repopulated the CD4/CD8
double-positive compartment (7.3% versus 46.8%). This
trend continued on day 5, at which time the Stat2 null
mice had almost returned to baseline. Recovery in the
Figure 5. T Cell Proliferation after a Dexamethasone Challenge
wild-type mice continued to lag behind, although less
Wild-type and Stat22/2 mice were intraperitoneally injected with 1.0
dramatically. These observations support a model mg dexamethasone or PBS vehicle. Two, four, and five days later,
where endogenously secreted IFNs serve to antagonize thymic cells were harvested, stained for CD4 and CD8, and evalu-
stress-dependent expansions of T cells through a Stat2- ated by flow cytometry. The number of cells present in each quad-
rant are indicated as a percent of total cells plotted. Similar resultsdependent pathway.
were obtained in three independent experiments.
Thirty-six hours after intravenous infection with 4 pfu of VSV, spleens
Discussion and livers were harvested. Viral burden (pfu/g) was determined by
measuring the viral titer of organ homogenates on HeLa cells. Or-
IFN receptor knockout studies have demonstrated that gans from four mice were included in each group.
type I and type II IFNs promote distinct biological re-
sponses (Huang et al., 1993; Mu¨ller et al., 1994; Lu et
al., 1998). Type I IFNs achieve this through the activation induction of ISGF-3 target genes, and stimulation of an
antiviral response. However, defects were also noted inof two transcription factors, ISGF-3 (Stat1 1 Stat2 1
IRF-9) and Stat1 homodimers. IFN-g (type II IFN) trans- the activation of GAS-driven genes. Previous studies
had suggested that Stat2 serves as the docking siteduces signals exclusively through Stat1 homodimers.
This led to the conclusion that Stat2 and ISGF-3 are necessary for Stat1 activation by type I IFNs (Leung et
al., 1995; Farrar et al., 2000). Although our studies inresponsible for the unique properties of type I IFNs
(Schindler and Strehlow, 2000). Although gene targeting Stat22/2 fibroblasts were consistent with this model, our
studies with Stat22/2 macrophages were not (see below).studies have confirmed the critical role Stat1 plays in
the biological response to type I and II IFNs, they have In addition, immunoblotting studies determined that the
level of Stat1 protein was reduced in Stat22/2 fibroblasts,provided little insight into the relative role of ISGF-3 and
Stat1 homodimers in the response to type I IFNs (Durbin suggesting a second reason for the defect in IFN-a-
stimulated Stat1 homodimer signaling.et al., 1996; Kimura et al., 1996; Meraz et al., 1996).
The generation of Stat2 knockout mice has, however, The reduced levels of Stat1 in the Stat22/2 fibroblasts
highlighted a previously unrecognized role for Stat2 inprovided an opportunity to explore the unique role Stat2
and ISGF-3 play in the biological response to type I the regulation of basal levels of this transcription factor
and raised the possibility of a Stat2-dependent auto-IFNs.
The initial studies were carried out in Stat22/2 fibro- crine loop. Consistent with this idea, previous studies
have determined that type I IFNs function in an autocrineblasts and indicated that these cells were defective in
their ability to mediate a number of responses to type manner, both in tumor lines (Resnitzky et al., 1986;
Mattei et al., 1994; Kawabata et al., 1997; Oritani et al.,I IFN. This included defects in the activation of ISGF-3,
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2000) and primary cells (Erlandsson et al., 1998; Sato et cate that the IFN-a-dependent regulation of MHC class
al., 1998; Takaoka et al., 2000). This loop mediates the I may vary in a tissue-specific manner. We find in fibro-
secretion of basal levels of type I IFN as well as the blasts that the IFN-a-stimulated expression of MHC
robust IRF-7-dependent production of late type I IFNs class I (as well as all target genes we examined) is de-
during viral infection (Marie et al., 1998; Sato et al., 1998; pendent on Stat2. For Stat1-dependent genes (i.e., GAS-
Takaoka et al., 2000). Additional roles have been sug- driven), this appears to be achieved both through the
gested for the autocrine loop as well (Lin et al., 1998; regulation of Stat1 levels and the IFN-a-dependent acti-
Lee et al., 1999; Marrack et al., 1999; Oritani et al., 2000). vation of Stat1. In contrast, in macrophages, IFN-a-stim-
The current study both supports the existence of this loop ulated expression of GAS-driven (i.e., Stat1 homodimer
in fibroblasts and splenocytes (see below) and dem- sites) genes is independent of Stat2. Of note, the IFN-
onstrates that it is Stat2 dependent. The data in fibro- a-dependent expression of MHC class I is a secondary
blasts include (1) the observation that both IFNAR12/2 and response. However, our studies indicate that expression
Stat22/2cells are inherently more susceptible to viral infec- of this locus is dependent on Stat1 homodimers (e.g.,
tion than wild-type cells, (2) the demonstration that reex- via IRF-1; Johnson and Pober, 1994). Thus, in striking
pression of Stat2 in Stat22/2 cells restores basal Stat1 contrast to what is found in fibroblasts, the IFN-a-induced
expression to it normal level, and (3) sensitive assays expression and activation of Stat1 in macrophages is inde-
demonstrating a basal level of ISGF-3 and target gene pendent of Stat2. This surprising dichotomy in type I IFN
expression in unstimulated MEFs (data not shown; Lee response may reflect the unique role macrophages play
et al., 1999; Takaoka et al., 2000). Of note, the forma- in regulating immune response. It also challenges the
tion of basal ISGF-3 activity correlated directly with cell notion that Stat2 is physically involved in the IFN-a-
density, was absent in Stat22/2 cells, and blocked by stimulated activation of Stat1 (Leung et al., 1995). In
the addition of IFN-a/b-blocking antibodies (data not sum, these observations define the critical role Stat2
shown). Finally, we would like to argue that the inability and ISGF-3 play in type I IFN biology and the pervasive
of Stat22/2 fibroblasts to mediate an effective antiviral role this family of IFNs plays in the regulation of immune
response to IFN-g stimulation (in vitro) is, at least in part, response.
a manifestation of this autocrine loop, as other studies
on IFNAR12/2 tissues have indicated (Mu¨ller et al., 1994; Experimental Procedures
Takaoka et al., 2000).
Generation of Stat2-Deficient MiceIndirect studies have suggested that the type I IFN
Screening a 129/Sv genomic phage library (Stratagene) with a mu-autocrine/paracrine loop serves to regulate lymphocyte
rine Stat2 cDNA probe led to the isolation of two overlapping geno-function. This includes studies identifying stromal and
mic clones (14.5 and 15.5 kb). After mapping the genomic locus, a
dendritic cells that secrete type I IFNs (Siegal et al., targeting vector consisting of a 7 kb 59 arm (a NotI/EcoRV fragment)
1999; Oritani et al., 2000) and studies demonstrating that and a 1.1 kb 39 arm (an XbaI/SalI fragment) was assembled in pBlue-
type I IFNs both downregulate lymphopoiesis (Binder et script (Figure 1A). The linearized targeting vector was electroporated
into W9.5 embryonic stem (ES) cells (gift of C. Stewart) and recombi-al., 1997; Lin et al., 1998) and promote the survival of
nants selected with G418 and gancyclovir (Wurst and Joyner, 1993).memory T cells, especially from the CD81 lineage (Tough
Homozygous null mutant ES lines were generated by raising theet al., 1996; Marrack et al., 1999). Studies on lympho-
level of G418 for Stat21/2 ES to 5 mg/ml (Mortenson et al., 1992).cytes from Stat22/2 mice support these observations.
To create Stat2 null mice, Stat22/2 ES cells were introduced into
They indicate that a Stat2-dependent autocrine/para- blastocysts harvested from RAG12/2 mice (Jackson Labs). Chimeric
crine loop regulates both the rapid expansion of lympho- male offspring were mated with 129Sv/J females to yield heterozy-
cytes in response to stress and the basal expression of gous Stat2 knockout mice. These were then intercrossed to homozy-
gosity. Recombination events were initially identified by Southerncell surface markers. Preliminary observations suggest
blotting with a SalI-BamHI (750 bp) genomic Stat2 DNA fragmentthat Stat2 may also participate in the IFN-a-dependent
that lies 39 to the targeted locus (probe SB; see Figure 1). However,preservation of memory T cells. This raises the question
subsequent genotyping was carried out either with a more robustas to how type I IFNs can mediate both an antiapoptotic
murine Stat2 cDNA probe (a PstI fragment spanning bp 1338–2118;
process in mature cells and an antiproliferative response probe P; see Figure 1; Park et al., 1999) or by PCR (common-39-
in immature cells. We hypothesize that both are depen- St2, GAGGTAAGAGGTTCCGAGTGTGTT; NeoP, CAGCGCATCGC
dent on the antiproliferative activity of these IFNs. In CTTCTATCGCCTTCTTG; and wt-59-St2, GGATTCTGAATCAGGCT
CAAAGAG). Stat1 null and IFNAR1 null mice were generous giftsimmature cells, the effect is direct, but, in mature cells,
from R. Schreiber and M. Aguet (Mu¨ller et al., 1994; Meraz et al.,a block in proliferation protects cells from programmed
1996). Stat1/Stat2 double knockout mice were obtained by crossingcell death. Perhaps some of these activities account for
the appropriate strains. Genotyping was done by established PCRthe beneficial effect of IFN-b in the treatment of multiple
assays (see above and Meraz et al., 1996) and confirmed by immu-
sclerosis. noblotting.
Another potentially important immunoregulatory re-
sponse of type I IFNs appears to be on the expression RNA
of MHC class I (Biron, 1998). The regulation of this locus Primary murine embryonic fibroblast (PMEF) RNA was prepared by
is complicated and involves at least three promoter ele- guanidinium isothiocyanate lysis (Chomczynski and Sacchi, 1987).
Immortalized murine embryonic fibroblast (MEF) RNA was preparedments (Martin et al., 1997). One element fits an ISRE
with RNazol (Life Technologies), as directed by the supplier. RNAconsensus site, binds IRF-1, and has been shown to
was fractionated on 1.0% agarose/formaldehyde gels, transferredregulate response to type I IFNs (Johnson and Pober,
to nylon membranes, and hybridized with [32P]cDNA probes labeled
1994). Consistent with the activity of an autocrine loop, to a specific activity of z5 3 108 cpm/mg (Random Prime Labeling;
recent studies have shown that the basal level of MHC Boehringer Mannheim and NEN). Probes included MxA cDNA (gift
class I expression is decreased in Stat1 knockout lym- of D. Levy), full-length OAS cDNA (gift of D. Levy), full-length PKR
cDNA (gift of A. Koromilas), full-length murine Stat1 cDNA (C. Schind-phocytes (Lee et al., 1999). Intriguingly, our studies indi-
Stat2 Knockout
803
ler, unpublished data), IRF-1 cDNA (Pine et al., 1994), IGTP cDNA For the dexamethasone challenge, mice were injected intraperito-
neally, with 1.0 mg dexamethasone (Sigma) or PBS in 200 ml bolus.(1.0 kb EcoRI fragment) (Taylor et al., 2000), and rat GAPDH cDNA
(Azam et al., 1997). Macrophage RNA was prepared with an After 2, 4, and 5 days, single-cell suspensions were prepared from
thymi, stained for CD4 and CD8, and analyzed by flow cytometry.RNAeasy kit, as directed (Qiagen), and then evaluated by RT-PCR.
In brief, 375 ng of total RNA was reverse transcribed with Super-
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